FOXD1 Expression Is Associated with Poor Prognosis in Non-small Cell Lung Cancer

被引：3
|
作者：
Nakayama, Sohei [1 ]
Soejima, Kenzo [1 ]
Yasuda, Hiroyuki [1 ]
Yoda, Satoshi [1 ]
Satomi, Ryosuke [1 ]
Ikemura, Shinnosuke [1 ]
Terai, Hideki [1 ]
Sato, Takashi [1 ]
Yamaguchi, Norihiro [2 ]
Hamamoto, Junko [1 ]
Arai, Daisuke [1 ]
Ishioka, Kota [1 ]
Ohgino, Keiko [1 ]
Naoki, Katsuhiko [1 ,3 ]
Betsuyaku, Tomoko [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Med, Div Pulm Med, Tokyo 1608582, Japan
[2] Beth Israel Deaconess Med Ctr, Dept Internal Med, New York, NY USA
[3] Keio Univ Hosp, Keio Canc Ctr, Tokyo, Japan
来源：
ANTICANCER RESEARCH | 2015年 / 35卷 / 01期
关键词：
FOXD1; non-small cell lung cancer; microarray; pathway signature; PTEN; GENE-EXPRESSION; PTEN LOSS; SIGNATURES; AKT; METASTASIS; SUPPRESSOR; ERLOTINIB; PROTEINS; SURVIVAL; FOXA2;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aim: Clinical microarray datasets were analyzed to search for new therapeutic targets and prognostic markers of non-small cell lung cancer (NSCLC). Materials and Methods: Microarray datasets from 90 lung cancer specimens, were analyzed with focus on the FOXD1 gene. Levels of FOXDI mRNA were assessed in lung cancer cell lines and these levels were correlated with survival. Results: FOXD1-knockdown led to suppression of cell proliferation. Moreover, patients with high FOXDI expression survived for a significantly shorter time than those with low FOXDI expression. Conclusion: The expression status of FOXD1 is a novel prognostic factor and may lead to new treatment strategies for NSCLC.
引用
收藏
页码：261 / 268
页数：8
相关论文
共 50 条
  • [1] MCAM expression is associated with poor prognosis in non-small cell lung cancer
    X. Zhang
    Z. Wang
    Y. Kang
    X. Li
    X. Ma
    L. Ma
    Clinical and Translational Oncology, 2014, 16 : 178 - 183
  • [2] MCAM expression is associated with poor prognosis in non-small cell lung cancer
    Zhang, X.
    Wang, Z.
    Kang, Y.
    Li, X.
    Ma, X.
    Ma, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (02): : 178 - 183
  • [3] EXPRESSION OF TRKB AND BDNF IS ASSOCIATED WITH POOR PROGNOSIS IN NON-SMALL CELL LUNG CANCER
    Okamura, Kyoko
    Harada, Taishi
    Wang, Shuo
    Furuyama, Kazuto
    Ijichi, Kayo
    Koga, Takaomi
    Okamoto, Tatsuro
    Takayama, Koichi
    Yano, Tokujiro
    Nakanishi, Yoichi
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S471 - S471
  • [4] Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer
    Okamura, Kyoko
    Harada, Taishi
    Wang, Shuo
    Ijichi, Kayo
    Furuyama, Kazuto
    Koga, Takaomi
    Okamoto, Tatsuro
    Takayama, Koichi
    Yano, Tokujiro
    Nakanishi, Yoichi
    LUNG CANCER, 2012, 78 (01) : 100 - 106
  • [5] Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients
    Grbesa, Ivana
    Pajares, Maria J.
    Martinez-Terroba, Elena
    Agorreta, Jackeline
    Mikecin, Ana-Matea
    Larrayoz, Marta
    Idoate, Miguel A.
    Gall-Troselj, Koraljka
    Pio, Ruben
    Montuenga, Luis M.
    PLOS ONE, 2015, 10 (04):
  • [6] Loss of ARID1A expression is associated with poor prognosis in non-small cell lung cancer
    Jang, Si-Hyong
    Lee, Ji-Hye
    Lee, Hyun Ju
    Cho, Hyundeuk
    Ahn, Hyein
    Song, In Hag
    Oh, Mee-Hye
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [7] Elevated expression of DTYMK is associated with poor prognosis in patients with Non-small cell lung cancer
    Wang, Wei
    Guo, Zhi-Hua
    Lu, Xin-Peng
    Liao, Dong-Jiang
    Peng, Gui-Lin
    Xu, Xin
    Yin, Wei-Qiang
    He, Jian-Xing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 22027 - 22033
  • [8] TRIM11 expression in non-small cell lung cancer is associated with poor prognosis
    Kuempers, Christiane
    Jagomast, Tobias
    Paulsen, Finn -Ole
    Heidel, Carsten
    Bohnet, Sabine
    Schierholz, Stefanie
    Reischl, Markus
    Dreyer, Eva
    Olchers, Till
    Kirfel, Jutta
    Reck, Martin
    Perner, Sven
    HISTOLOGY AND HISTOPATHOLOGY, 2024, 39 (04) : 437 - 446
  • [9] L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer
    Verena Tischler
    Marco Pfeifer
    Silke Hausladen
    Uwe Schirmer
    Anne-Katrine Bonde
    Glen Kristiansen
    Martin L Sos
    Walter Weder
    Holger Moch
    Peter Altevogt
    Alex Soltermann
    Molecular Cancer, 10
  • [10] L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer
    Tischler, Verena
    Pfeifer, Marco
    Hausladen, Silke
    Schirmer, Uwe
    Bonde, Anne-Katrine
    Kristiansen, Glen
    Sos, Martin L.
    Weder, Walter
    Moch, Holger
    Altevogt, Peter
    Soltermann, Alex
    MOLECULAR CANCER, 2011, 10 : 127
12345